SynthesisMedicine2019

Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis.

Se Ik Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.